市場調査レポート

ニードルフリードラッグデリバリーデバイス市場(ジェットインジェクターおよび競合する無針技術;ワクチンデリバリー 、疼痛管理、インシュリン投与、小児用注射器) - 世界業界分析、市場規模、シェア、成長、動向および予測

Needle Free Drug Delivery Devices Market (Jet Injectors and Competing Needle-Free Technologies; Vaccine Delivery, Pain Management, Insulin Delivery, Pediatric Injections) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

発行 Transparency Market Research 商品コード 305296
出版日 ページ情報 英文 70 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。
Back to Top
ニードルフリードラッグデリバリーデバイス市場(ジェットインジェクターおよび競合する無針技術;ワクチンデリバリー 、疼痛管理、インシュリン投与、小児用注射器) - 世界業界分析、市場規模、シェア、成長、動向および予測 Needle Free Drug Delivery Devices Market (Jet Injectors and Competing Needle-Free Technologies; Vaccine Delivery, Pain Management, Insulin Delivery, Pediatric Injections) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023
出版日: 2016年04月16日 ページ情報: 英文 70 Pages
概要

ニードルフリードラッグデリバリーデバイスは、従来型の針を皮膚に侵襲させることなく患者の体内に薬剤を導入できる新しい技術で、幅広い薬剤の投与を効果的にするものです。シリンジ・ニードルと生物学的に同等であり、その結果痛みを低減させるものです。

当レポートでは、ニードルフリードラッグデリバリーデバイス市場の現状と将来的可能性、技術および用途別動向、2013〜2023年までの予測、地域別動向とともに、参入企業のプロファイルをまとめています。

第1章 序論

第2章 エグゼクティブサマリー

第3章 産業分析

  • イントロダクション
  • 市場動向
    • 促進因子
    • 阻害因子
    • 市場の機会
  • ポーターズファイブフォース分析
  • 市場の魅力度分析
  • 競合情勢

第4章 技術別市場

  • イントロダクション
  • 技術別市場収益
  • ジェットインジェクター
  • 競合技術
    • 世界の競合するニードルフリー技術市場収益
    • 吸入器技術
    • 経皮パッチ技術

第5章 用途別市場

  • イントロ
  • 用途別市場収益
  • ワクチンデリバリー
  • 疼痛管理
  • 糖尿病用インスリン投与
  • 小児用注射器
  • その他の用途

第6章 地域別市場

  • イントロダクション
  • 地域別市場
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ地域

第7章 提言

第8章 企業プロファイル

  • 3M
  • Antares Pharma, Inc.
  • Glide Pharmaceutical Technologies Ltd.
  • Injex Pharma AG
  • Pharmajet, Inc.
  • Zogenix, Inc.

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

This report on the needle free drug delivery devices market analyzes the current and future scenario of the global market. Large number of chronic pain and diabetes sufferers is increasing the usage of needle free drug delivery devices. Less pain and consistency in drug delivery are the major drivers of the global needle free drug delivery devices market.

The needle free drug delivery devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global needle free drug delivery devices market.

Based on technology, the market has been segmented into jet injectors and competing needle-free technologies. The competing needle-free technologies segment has been further divided into novel needle technology, inhaler technology, and transdermal patch technology. Novel needle technology includes micro-needle and pen needle. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on application, the needle free drug delivery devices market has been segmented into five major categories: vaccine delivery, pain management, insulin delivery, pediatric injections, and others. Other applications of needle free drug delivery devices include angina, hypertension, and other medical conditions. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the global needle free drug delivery devices market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, and Rest of Europe), Asia Pacific (Japan, China, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global needle free drug delivery devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Zogenix, Inc., 3M Health Care, Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, and Pharmajet, Inc.

The global needle free drug delivery devices market has been segmented as follows:

Global Needle Free Drug Delivery Devices Market Revenue, by Technology, (US$ Mn), 2013-2023

  • Jet Injectors
  • Competing Needle-free Technologies
    • Novel Needle Technology
    • Inhaler Technology
    • Transdermal Patch Technology

Global Needle Free Drug Delivery Devices Market Revenue, by Application, (US$ Mn), 2013-2023

  • Vaccine Delivery
  • Pain Management
  • Insulin Delivery
  • Pediatric Injections
  • Other Applications

Global Needle Free Drug Delivery Devices Market Revenue, By Geography, (US$ Mn), 2013-2023

  • Overview
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

  • 2.1. Global Needle Free Drug Delivery Devices Market Share, by Geography, 2014-2023 (US$ Mn)
  • 2.2. Global Needle Free Drug Delivery Devices Market, by Technology and Application, 2014 (US$ Mn)
  • 2.3. Needle Free Drug Delivery Devices: Market Snapshot

3. Needle Free Drug Delivery Devices Market - Industry Analysis

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Porter's Five Forces Analysis
  • 3.4. Market Attractiveness Analysis - Needle Free Drug Delivery Devices Market, by Geography (2014) (%)
  • 3.5. Competitive Landscape - Needle Free Drug Delivery Devices Market, by Key Players, 2014 (%)

4. Market Segmentation - By Technology

  • 4.1. Introduction
  • 4.2. Global Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013-2023 (US$ Mn)
  • 4.3. Global Jet Injectors Market Revenue, 2013-2023 (US$ Mn)
  • 4.4. Global Competing Needle Free Technology Market Revenue, 2013-2023 (US$ Mn)
    • 4.4.1. Global Novel Needle Technology Market Revenue, 2013-2023 (US$ Mn)
    • 4.4.2. Global Inhaler Technology Market Revenue, 2013-2023 (US$ Mn)
    • 4.4.3. Global Transdermal Patch Technology Market Revenue, 2013-2023 (US$ Mn)

5. Market Segmentation - By Application

  • 5.1. Introduction
  • 5.2. Global Needle Free Drug Delivery Devices Market Revenue, by Application, 2013-2023 (US$ Mn)
  • 5.3. Global Vaccine Delivery Market Revenue, 2013-2023 (US$ Mn)
  • 5.4. Global Pain Management Market Revenue, 2013-2023 (US$ Mn)
  • 5.5. Global Insulin Delivery for Diabetes Market Revenue, 2013-2023 (US$ Mn)
  • 5.6. Global Pediatric Injections Market Revenue, 2013-2023 (US$ Mn)
  • 5.7. Global Other Applications Market Revenue, 2013-2023 (US$ Mn)

6. Market Segmentation - By Geography

  • 6.1. Introduction
  • 6.2. Global Needle Free Drug Delivery Devices Market Revenue, by Geography, 2013-2023 (US$ Mn)
  • 6.3. North America Needle Free Drug Delivery Devices Market Revenue, 2013-2023 (US$ Mn)
  • 6.4. Europe Needle Free Drug Delivery Devices Market Revenue, 2013-2023 (US$ Mn)
  • 6.5. Asia Pacific Needle Free Drug Delivery Devices Market Revenue, 2013-2023 (US$ Mn)
  • 6.6. Latin America Needle Free Drug Delivery Devices Market Revenue, 2013-2023 (US$ Mn)
  • 6.7. Middle East & Africa Needle Free Drug Delivery Devices Market Revenue, 2013-2023 (US$ Mn)

7. Recommendations

8. Company Profiles

  • 8.1. 3M
  • 8.2. Antares Pharma, Inc.
  • 8.3. Glide Pharmaceutical Technologies Ltd.
  • 8.4. Injex Pharma AG
  • 8.5. Pharmajet, Inc.
  • 8.6. Zogenix, Inc.

List of Figures

  • FIG. 1 Needle Free Drug Delivery: Market Segmentation
  • FIG. 2 Global Needle-free Drug Delivery Devices Market Share, by Geography, 2014
  • FIG. 3 Global Needle-free Drug Delivery Devices Market Share, by Geography, 2023
  • FIG. 4 Global Needle-free Drug Delivery Devices Market, by Geography, 2014, Value (%)
  • FIG. 5 Global Needle-free Drug Delivery Devices Market, by Key Players, 2014 (%)
  • FIG. 6 Global Jet Injectors Market Revenue, 2013-2023, (US$ Mn)
  • FIG. 7 Global Novel Needle Technology Market Revenue, 2013-2023, (US$ Mn)
  • FIG. 8 Global Inhaler Technology Market Revenue, 2013-2023, (US$ Mn)
  • FIG. 9 Global Transdermal Patch Technology Market Revenue, 2013-2023, (US$ Mn)
  • FIG. 10 Global Vaccine Delivery Market Revenue, 2013-2023, (US$ Mn)
  • FIG. 11 Global Pain Management Market Revenue, 2013-2023, (US$ Mn)
  • FIG. 12 Global Insulin Delivery for Diabetes Market Revenue, 2013-2023, (US$ Mn)
  • FIG. 13 Global Pediatric Injections Market Revenue, 2013-2023, (US$ Mn)
  • FIG. 14 Global Other Applications Market Revenue, 2013-2023, (US$ Mn)
  • FIG. 15 3 M Health Care: Financial Overview: 2012-2014 (US$ Mn)
  • FIG. 16 Antares Pharma, Inc.: Financial Overview: 2012-2014 (US$ Mn)
  • FIG. 17 Zogenix, Inc.: Financial Overview: 2012-2014 (US$ Mn)

List of Tables

  • TABLE 1: Needle-free Drug Delivery Devices: Market Snapshot
  • TABLE 2: Global Needle-Free Drug Delivery Devices Market Revenue, by Technology, 2013-2023, (US$ Mn)
  • TABLE 3: Global Competing Needle Free Technology Market Revenue, by Type, 2013-2023, (US$ Mn)
  • TABLE 4: Global Needle Free Drug Delivery Devices Market Revenue, by Application, 2013-2023, (US$ Mn)
  • TABLE 5: Global Needle-Free Drug Delivery Devices Market Revenue, by Geography, 2013-2023 (US$ Mn)
  • TABLE 6: North America Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013-2023 (US$ Mn)
  • TABLE 7: North America Needle Free Drug Delivery Devices Market Revenue, by Country, 2013-2023 (US$ Mn)
  • TABLE 8: Europe Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013-2023 (US$ Mn)
  • TABLE 9: Europe Needle Free Drug Delivery Devices Market Revenue, by Country, 2013-2023 (US$ Mn)
  • TABLE 10: Asia Pacific Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013-2023 (US$ Mn)
  • TABLE 11: Asia Pacific Needle Free Drug Delivery Devices Market Revenue, by Country, 2013-2023 (US$ Mn)
  • TABLE 12: Latin America Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013-2023 (US$ Mn)
  • TABLE 13: Latin America Needle Free Drug Delivery Devices Market Revenue, by Country, 2013-2023 (US$ Mn)
  • TABLE 14: Middle East and Africa Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013-2023 (US$ Mn)
  • TABLE 15: Middle East & Africa Needle Free Drug Delivery Devices Market Revenue, by Country, 2013-2023 (US$ Mn)
Back to Top